Abbott Stock Today


USD 109.45  2.48  2.32%   

Market Performance
0 of 100
Odds Of Distress
Less than 11
Abbott Laboratories is selling for under 109.45 as of the 29th of June 2022; that is 2.32 percent increase since the beginning of the trading day. The stock's last reported lowest price was 106.43. Abbott Laboratories has less than a 11 % chance of experiencing some financial distress in the next two years of operation, but has generated negative returns over the last 90 days. Equity ratings for Abbott Laboratories are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 30th of May 2022 and ending today, the 29th of June 2022. Click here to learn more.
Fiscal Year End
Business Domain
Health Care Equipment & Services
IPO Date
13th of January 1978
Health Care
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Abbott Laboratories operates under Medical Devices classification in the United States and is traded on New York Stock Exchange. The company has 1.77 B outstanding shares of which 13.46 M shares are presently shorted by investors with about 2.65 days to cover. More on Abbott Laboratories

Moving together with Abbott Laboratories

0.8ARAYAccuray Fiscal Year End 10th of August 2022 PairCorr
0.82CSIICardiovascular Syst Fiscal Year End 3rd of August 2022 PairCorr
0.77CUTRCutera Inc Normal TradingPairCorr
Follow Valuation Options Odds of Bankruptcy
Check how we calculate scores

Abbott Laboratories Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. If you consider yourself one of those investors, make sure you clearly understand your entering position. Abbott Laboratories' investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Abbott Laboratories or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
Abbott Laboratories generated a negative expected return over the last 90 days
Abbott Laboratories has a poor financial position based on the latest SEC disclosures
Over 76.0% of the company shares are held by institutions such as insurance companies
Latest headline from Why Investors Should Focus on Abbotts Medical Devices - Nasdaq
ESG SustainabilitySome studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary, Abbott Laboratories' sustainability indicators can be used to identify a proper investment strutegies using environmental, social, and governance scores that are crucial to Abbott Laboratories' managers, analysts, and investors.
Environment Score
Governance Score
Social Score
CEORobert Ford
SEC FilingsAbbott Laboratories Security & Exchange Commission EDGAR Reports
Thematic Ideas
Showing 3 out of 4 themes
Excise Tax ActivitiesAnimal TestingCatholic
Fama & French Classification
Average Analyst Recommendation
Analysts covering Abbott Laboratories report their recommendations after researching Abbott Laboratories' financial statements, talking to executives and customers, or listening in on Abbott Laboratories' conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Abbott Laboratories. The Abbott consensus assessment is calculated by taking the average forecast from all of the analysts covering Abbott Laboratories.
Piotroski F Score
Piotroski F-Score is a popular financial indicator that puts together nine criteria to evaluate the financial strength of Abbott Laboratories based on its profitability, leverage, liquidity, source of funds, and operating efficiency. It is an academic score (developed by Joseph Piotroski in 2002) to determine the current strength of Abbott Laboratories financial position. Scores of 8 and 9 are usually classified as strong value stocks, whereas scores of 2 or below are considered weak value stocks.
 4 - PoorDetails
Current ValueLast YearChange From Last Year 10 Year Trend
Weighted Average Shares1.9 B1.8 B
Notably Up
Slightly volatile
Weighted Average Shares Diluted1.9 B1.8 B
Notably Up
Slightly volatile
Net Cash Flow from Operations9.1 B10.5 B
Fairly Down
Total Assets74.6 B75.2 B
Slightly Down
Slightly volatile
Total Liabilities39.7 B39.2 B
Fairly Up
Slightly volatile
Current Assets21.3 B24.2 B
Fairly Down
Current Liabilities11.4 B13.1 B
Fairly Down
Slightly volatile
Total Debt19.2 B18.1 B
Notably Up
Slightly volatile
Return on Average Assets0.07650.096
Significantly Down
Gross Margin0.630.57
Significantly Up
Slightly volatile
Asset Turnover0.570.584
Fairly Down
Slightly volatile
Macroaxis Advice
Unlike general analyst consensus, Macroaxis buy hold or sell recommendation is provided in the context of your current investment horizon and risk tolerance. The advice algorithm takes into account all of Abbott Laboratories' available fundamental, technical, and predictive indicators. Your current horizon is 90 days - details
Financial Strength
Abbott Laboratories' financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Abbott Laboratories' success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Abbott Laboratories' bond ratings measure its overall creditworthiness, which in many ways corresponds to the cost of borrowing for an issuer. These ratings assign a letter grade to all of Abbott Laboratories' outstanding corporate bonds that indicate their credit quality. We use reports published by private self-sufficient rating services such as Standard & Poor's or Fitch Ratings Inc. to evaluate a bond issuer's financial strength or its ability to pay a bond's principal and interest.
N/A ( Average Bond Rating ) Not Rated
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Abbott Laboratories' financial leverage. It provides some insight into what part of Abbott Laboratories' total assets is financed by creditors.
Share Download
Share Download
By using current balance sheet information, investors can analyze the liability, assets, and equity on Abbott Laboratories' books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Abbott Laboratories deploys its capital and how much of that capital is borrowed.
Abbott Laboratories cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company has 19.25 B in debt with debt to equity (D/E) ratio of 0.53, which is OK given its current industry classification. Abbott Laboratories has a current ratio of 1.79, which is typical for the industry and considered as normal. Debt can assist Abbott Laboratories until it has trouble settling it off, either with new capital or with free cash flow. So, Abbott Laboratories' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Abbott Laboratories sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Abbott to invest in growth at high rates of return. When we think about Abbott Laboratories' use of debt, we should always consider it together with cash and equity.

Operating Cash Flow

9.12 BillionShare
Abbott Laboratories (ABT) is traded on New York Stock Exchange in USA. It is located in 100 Abbott Park Road, Abbott Park, IL 60064-6400, United States and employs 113,000 people. Abbott Laboratories is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 189.15 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Abbott Laboratories's market, we take the total number of its shares issued and multiply it by Abbott Laboratories's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities. Abbott Laboratories runs under Healthcare sector within Medical Devices industry. The entity has 1.77 B outstanding shares of which 13.46 M shares are presently shorted by investors with about 2.65 days to cover. Abbott Laboratories has about 10.25 B in cash with 11.26 B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 5.81.
Check Abbott Laboratories Probability Of Bankruptcy
Abbott Laboratories holds a total of one billion seven hundred seventy million outstanding shares. The majority of Abbott Laboratories outstanding shares are owned by other corporate entities. These outside corporations are usually referred to as non-private investors looking to acquire positions in Abbott Laboratories to benefit from reduced commissions. Consequently, institutional investors are subject to a different set of regulations than regular investors in Abbott Laboratories. Please pay attention to any change in the institutional holdings of Abbott Laboratories as this could imply that something significant has changed or about to change at the company. Please note that no matter how much assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.

Ownership Allocation (%)

Check Abbott Ownership Details

Abbott Stock Price Odds Analysis

What are Abbott Laboratories' target price odds to finish over the current price? Attributed to a normal probability distribution, the odds of Abbott Laboratories jumping above the current price in 90 days from now is about 80.17%. The Abbott Laboratories probability density function shows the probability of Abbott Laboratories stock to fall within a particular range of prices over 90 days. Considering the 90-day investment horizon the stock has a beta coefficient of 1.0603. This suggests Abbott Laboratories market returns are related to returns on the market. As the market goes up or down, Abbott Laboratories is expected to follow. Additionally, the company has an alpha of 0.0504, implying that it can generate a 0.0504 percent excess return over DOW after adjusting for the inherited market risk (beta).
  Odds Below 109.45HorizonTargetOdds Above 109.45
19.66%90 days
Based on a normal probability distribution, the odds of Abbott Laboratories to move above the current price in 90 days from now is about 80.17 (This Abbott Laboratories probability density function shows the probability of Abbott Stock to fall within a particular range of prices over 90 days) .

Abbott Laboratories Historical Income Statement

Abbott Laboratories Income Statement is one of the three primary financial statements used for reporting Abbott's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Abbott Laboratories revenue and expense. Abbott Laboratories Income Statement primarily focuses on the company's revenues and expenses during a particular period.
Abbott Laboratories Interest Expense is comparatively stable at the moment as compared to the past year. Abbott Laboratories reported Interest Expense of 533 Million in 2021. Operating Income is likely to gain to about 9.1 B in 2022, whereas Cost of Revenue is likely to drop slightly above 16.4 B in 2022. View More Fundamentals

Abbott Stock Against Markets

Picking the right benchmark for Abbott Laboratories stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Abbott Laboratories stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Abbott Laboratories is critical whether you are bullish or bearish towards Abbott Laboratories at a given time.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Abbott Laboratories without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Bond Directory Now


Bond Directory

Find actively traded corporate debentures issued by US companies
All  Next Launch Module

Abbott Laboratories Corporate Directors

Abbott Laboratories corporate directors refer to members of an Abbott Laboratories board of directors. The board of directors generally takes responsibility for the Abbott Laboratories' affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of Abbott Laboratories' board members must vote for the resolution. The Abbott Laboratories board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.
Samuel Scott - Independent DirectorProfile
James Farrell - Independent DirectorProfile
Phebe Novakovic - Independent DirectorProfile
Roxanne Austin - Independent DirectorProfile

Investing Abbott Laboratories

You need to understand the risk of investing before taking a position in Abbott Laboratories. The danger of trading Abbott Laboratories is mainly related to its market volatility and company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Abbott Laboratories is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Abbott Laboratories. The Shape ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Abbott Laboratories is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
Please continue to Trending Equities. Note that the Abbott Laboratories information on this page should be used as a complementary analysis to other Abbott Laboratories' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Commodity Channel Index module to use Commodity Channel Index to analyze current equity momentum.

Complementary Tools for Abbott Stock analysis

When running Abbott Laboratories price analysis, check to measure Abbott Laboratories' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Abbott Laboratories is operating at the current time. Most of Abbott Laboratories' value examination focuses on studying past and present price action to predict the probability of Abbott Laboratories' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Abbott Laboratories' price. Additionally, you may evaluate how the addition of Abbott Laboratories to your portfolios can decrease your overall portfolio volatility.
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Transaction History
View history of all your transactions and understand their impact on performance
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
ETF Directory
Find actively traded Exchange Traded Funds (ETF) from around the world
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Analyst Recommendations
Analyst recommendations and target price estimates broken down by several categories
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Is Abbott Laboratories' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Abbott Laboratories. If investors know Abbott will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Abbott Laboratories listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth YOY
Market Capitalization
191 B
Quarterly Revenue Growth YOY
Return On Assets
Return On Equity
The market value of Abbott Laboratories is measured differently than its book value, which is the value of Abbott that is recorded on the company's balance sheet. Investors also form their own opinion of Abbott Laboratories' value that differs from its market value or its book value, called intrinsic value, which is Abbott Laboratories' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Abbott Laboratories' market value can be influenced by many factors that don't directly affect Abbott Laboratories' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Abbott Laboratories' value and its price as these two are different measures arrived at by different means. Investors typically determine Abbott Laboratories value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Abbott Laboratories' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.